Education, Science, Technology, Innovation and Life
Open Access
Sign In
  1. Home
  2. Journals
  3. MEDS Chinese Medicine
  4. Vol 5, Issue 5, 2023

Xu Jianqin's Medication Rules of Safflower in the Treatment of Diabetes Mellitus and Its Complications Based on the Traditional Chinese Medicine Inheritance Assistance Platform

Download as PDF

DOI: 10.23977/medcm.2023.050506 | Downloads: 8 | Views: 368

Author(s)

Wu Yun 1, Qu Kai 2, Zhou Ting 1, Ding Yanlin 1, Xie Lei 1, Xu Jianqin 2

Affiliation(s)

1 Shaanxi University of Chinese Medicine, Xianyang, China
2 Shaanxi Province Hospital of Traditional Chinese Medicine, Xi'an, China

Corresponding Author

Xu Jianqin

ABSTRACT

Our purpose is to investigate the clinical application of Xu Jianqin, chief physician, in the treatment of diabetes mellitus and its complications based on data mining. Our method was to collect 222 medical records of chief physician Xu Jianqin's outpatient clinic that contained safflower in the treatment of diabetes and its complications (including 74 cases of safflower in the treatment of diabetes and 148 cases of safflower in the treatment of diabetic complications). The "TCM Inheritance Auxiliary platform (V2.5)" was used to mine and analyze the syndrome distribution, core medication, association rules and cluster analysis of the data. The results of this study were as follows: there are 128 traditional Chinese medicines were included in 222 data collected. Among the medical records of safflower treatment for diabetes and its complications, there were 7 safflower dosage frequency ≥10 times, which were 12g, 6g, 9g and 15g in descending order, respectively. There were 12 kinds of symptoms ≥50 times of safflower in the treatment of diabetes and its complications. In the two databases, there are 26 kinds of drug combination patterns, 13 kinds of drug combination patterns, 44 association rules, 25 association rules, and 3 core combinations were obtained by association rules and cluster analysis, respectively. We concluded that by summarizing the rules of Doctor Xu's application of safflower in the treatment of this disease, we analyzed that safflower can remove the visible stasis and prevent the stagnation that has not yet formed, so as to provide reference value for the clinical application of safflower in the later stage.

KEYWORDS

Safflower, Diabetes, Diabetes complications, Xu Jianqin, TCM Inheritance Support Platform

CITE THIS PAPER

Wu Yun, Qu Kai, Zhou Ting, Ding Yanlin, Xie Lei, Xu Jianqin, Xu Jianqin's Medication Rules of Safflower in the Treatment of Diabetes Mellitus and Its Complications Based on the Traditional Chinese Medicine Inheritance Assistance Platform. MEDS Chinese Medicine (2023) Vol. 5: 38-44. DOI: http://dx.doi.org/10.23977/medcm.2023.050506.

REFERENCES

[1] Zhu Dalong. Chinese Guidelines for the Prevention and Treatment of Type 2 Diabetes (2020 Edition) [J]. Chinese Journal of Practical Internal Medicine 2021, 41(09):757-784. 
[2] Brussels Belgium, International Diabetes Federation. IDF Diabetes Atlas, 10th edn [EB/OL]. International Diabetes Federation, 2021. 
[3] Guo Lixin. Significant Progress in the Field of Diabetes in 2021 [J]. Chinese Medical Information Herald, 2021, 36 (24): 10-11. 
[4] Diwu Yongchang, Xu Jianqin. Rethinking on the pathological connotation of "spleen does not disperse essence" in TCM [J]. Shaanxi TCM, 2006 (11): 1390-1392. 
[5] Jia Xiaojie, Liu Zhiyue. Research Progress of Carthamus tinctorius Preparation in Diabetes and Its Complications [J]. Western Chinese Medicine, 2013, 26 (03): 127-129. 
[6] Han Mengdi, Ma Feixiang, Wang Yanan, et al. Investigating the active ingredients and pharmacological mechanism of safflower based on network pharmacology [J]. Journal of Inner Mongolia Medical University, 2019, 41 (02): 126-130. 
[7] Chinese Pharmacopoeia Commission. Pharmacopoeia of the People's Republic of China: Volume I [M]. Beijing: China Medical Science and Technology Press, 2020. 
[8] Zhang Zhicong. Huang Di Nei Jing Ji Zhu Xia Lingshu [M]. Beijing: China Medical Science and Technology Publication, 2015. 
[9] Zhang Qi. Jin Kui Yao Lue Jiang Yi [M]. Shanghai: Shanghai Science and Technology Publication, 2020. 
[10] Tang Yang, Li Wensheng, Liu Ximing. Brief analysis of Li Dongyuan's use of "a little safflower" [J]. Chinese Medicine Information, 2018, 35 (03): 45-46. 
[11] Li Gao. Jin, Lan Shi Mi Cang (M). Beijing: Ancient Book Press of Traditional Chinese Medicine, 1986. 9. 
[12] Zhang Nianshun, Li Dongyuan Medical Book (M). Beijing: China Traditional Chinese Medicine Press, 2006, 1. 
[13] Li Shizhen, Ming, Ben Cao Gang Mu (M). Beijing: People's Medical Publishing House, 1975. 
[14] Gong Yanxian, Ming, Yao Xing Ge Kuo Si Bai Wei (M). Shanghai: Shanghai University of Traditional Chinese Medicine Press, 2006. 
[15] Liang Wulin, Zhang Mingqian, Cui Shuang, et al. Progress in pharmacological action and clinical application of safflower in protecting cardiovascular system [J]. Journal of Traditional Chinese Medicine, 2022, 05 (06): 94-102. 
[16] Li Xinrui, Liu Juan, Peng Cheng, et al. Progress in Chemical Composition and Pharmacological Activity of Carthamus tinctorius [J]. Journal of Chengdu University of Traditional Chinese Medicine. 2021, 44 (01): 102-112. 
[17] Zhao Jinming, Qin Wenyan, Qi Yue, et al. Study on anticoagulant effect of safflower yellow pigment and its effect on platelet aggregation [J]. Laboratory Animal Science, 2009, 26 (06): 30-32. 
[18] Tian Zhiwei. Pharmacological Analysis and Clinical Application of Carthamus tinctorius [J]. Journal of Clinical Medical Literature, 2017, 4 (80): 15833. 
[19] Shi Min, Chen Lei, Gong Jiajia, et al. Progress in Safflower Yellow Pigment [J]. World Latest Medical Information, 2018, 18 (08): 20-29. 
[20] Zhang Han, Zhao Yuxia, Yang Huiran, et al. Effect of safflower yellow pigment on high glucose-induced podocyte injury in mice and its mechanism [J]. Chinese patent medicine, 2021, 43 (11): 3007-3013.

Subscription
E-Mail Alert
Most popular papers
Call for Special Issue
Publication Ethics & OA Statement
Plagiarism Policy
Contact Us
Downloads: 4104
Visits: 161859

Sponsors, Associates, and Links

All published work is licensed under a Creative Commons Attribution 4.0 International License.

Copyright © 2016 - 2031 Clausius Scientific Press Inc. All Rights Reserved.